Share on Facebook Share on Twitter Email
Answers.com

osteoporosis

Did you mean: osteoporosis (disease), How serious is osteoporosis? (anatomy)

 
Medical Encyclopedia: Osteoporosis
 

Definition

The word osteoporosis literally means "porous bones." It occurs when bones lose an excessive amount of their protein and mineral content, particularly calcium. Over time, bone mass, and therefore bone strength, is decreased. As a result, bones become fragile and break easily. Even a sneeze or a sudden movement may be enough to break a bone in someone with severe osteoporosis.

Description

Osteoporosis is a serious public health problem. Some 28 million people in the United States are affected by this potentially debilitating disease, which is responsible for 1.5 million fractures (broken bones) annually. These fractures, which are often the first sign of the disease, can affect any bone, but the most common locations are the hip, spine, and wrist. Breaks in the hip and spine are of special concern because they almost always require hospitalization and major surgery, and may lead to other serious consequences, including permanent disability and even death.

To understand osteoporosis, it is helpful to understand the basics of bone formation. Bone is living tissue that's constantly being renewed in a two-stage process (resorption and formation) that occurs throughout life. In the resorption stage, old bone is broken down and removed by cells called osteoclasts. In the formation stage, cells called osteoblasts build new bone to replace the old. During childhood and early adulthood, more bone is produced than removed, reaching its maximum mass and strength by the mid-30s. After that, bone is lost at a faster pace than it's formed, so the amount of bone in the skeleton begins to slowly decline. Most cases of osteoporosis occur as an acceleration of this normal aging process. That's referred to as primary osteoporosis. The condition can also be caused by other disease processes or prolonged use of certain medications that result in bone loss—if so, it's called secondary osteoporosis.

Osteoporosis occurs most often in older people and in women after menopause. It affects nearly half of all those, men and women, over the age of 75. Women, however, are five times more likely than men to develop the disease. They have smaller, thinner bones than men to begin with, and they lose bone mass more rapidly after menopause (usually around age 50), when they stop producing a bone-protecting hormone called estrogen. In the five to seven years following menopause, women can lose about 20% of their bone mass. By age 65 or 70, though, men and women lose bone mass at the same rate. As an increasing number of men reach an older age, there's more awareness that osteoporosis is an important health issue for them as well.

— Barbara Boughton



Search unanswered questions...
Enter a word or phrase...
All Community Q&A Reference topics
Dictionary: os·te·o·po·ro·sis   (ŏs'tē-ō-pə-rō'sĭs) pronunciation
 
n., pl. -ses (-sēz).

A disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse.

[New Latin : OSTEO– + Greek poros, passage, pore; see pore2 + –OSIS.]

osteoporotic os'te·o·po·rot'ic (-rŏt'ĭk) adj.
 
Sci-Tech Encyclopedia: Osteoporosis
Top

A metabolic bone disease in which the amount of bone tissue is reduced sufficiently to increase the likelihood of fracture. Fractures of the vertebrae, femur (hip), and wrist are the most common osteoporotic fractures, but other bones such as the ribs, upper arm, and pelvis may also fracture.

Although low bone mass is the major factor in osteoporotic fractures, there may also be qualitative and architectural changes in bone with aging that lead to increased fragility. Osteoporosis can be primary or secondary. Primary osteoporosis occurs independently of other causes. The secondary osteoporoses result from identifiable causes, such as exogenous cortisone administration, Cushing's disease, hyperparathyroidism, hyperthyroidism, hypogonadism, multiple myeloma, prolonged immobilization, alcoholism, anorexia nervosa, and various gastrointestinal disorders. Primary osteoporosis occurring in children is called juvenile osteoporosis; that occurring in premenopausal women and middle-aged or young men is known as idiopathic osteoporosis. Osteoporosis, which is found in older persons, can be classified as postmenopausal (type I) or involutional (type II) osteoporosis. See also Alcoholism; Anorexia nervosa; Gastrointestinal tract disorders; Metabolic disorders.

Goals should include prevention of both the underlying disorder (the disease) and its effects (osteoporotic fractures). Secondary osteoporoses are managed by eliminating the underlying disorder. To prevent primary osteoporosis, good health-related behavior during childhood and young adulthood has been suggested as the most important factor. Such behavior includes avoiding cigarette smoking and excess alcohol intake, maintaining a normal body weight, and maintaining optimal dietary intake of calcium. It has been suggested that the recommended daily allowance (RDA) for calcium in the postmenopausal period and the recommended intake of vitamin D in the aged should be increased. At menopause, the possibility of estrogen replacement therapy should be considered for women who are at high risk for osteoporosis. Fracture prevention should be a lifelong effort. During childhood and the premenopausal years, a maximal peak bone mass should be developed through weight-bearing exercise. Exercise to improve coordination and flexibility and to maintain good posture is also useful. See also Estrogen; Nutrition; Vitamin D.

The diagnosis of primary osteoporosis is made in the presence of either low bone mass or a characteristic fracture that cannot be attributed to some other cause.

The goals of treatment are rehabilitation and minimization of the risk of future fractures. Goals for rehabilitation include restoring a positive outlook on life, treating depression if it exists, increase of physical activity, restoring independence, relieving pain, restoring muscle mass, and improving posture. Various medications, including estrogen and calcitonin, can maintain bone mass. See also Aging; Bone; Skeletal system disorders.


 
World of the Body: osteoporosis
Top

Osteoporosis is a condition in which the bones become porous and weak, and therefore fracture easily. The bone tissue is normal with a normal shape but it has lost mass and density and so lacks sufficient strength to withstand the forces which normally occur in daily life. There are no symptoms initially and the condition is often diagnosed only when a bone fracture occurs unexpectedly. These fractures occur in a third of all women and in one in twelve men. Post-menopausal and senile osteoporosis are recognized. The former is due to loss of oestrogen, the latter includes a time-dependent loss of bone common to men and women. Osteoporosis also occurs as a side-effect of some drug treatments, with oral corticosteroids for example, and occasionally, in a severe and little understood form at much younger ages.

Osteoporosis is often confused with osteoarthritis, another chronic problem of later life. However, osteoarthritis is a disease of the joints which is rare in those who have osteoporosis (unless they have been treated with corticosteroids).

Osteoporosis is not a disease like those caused by viral or bacterial infection, but a long term consequence of a small imbalance in the natural process of bone remodelling. Bone is a living tissue which constantly remodels itself through a process of resorption and formation known as bone turnover. Most processes in the body slow down as we grow older but bone turnover speeds up and the balance tips in favour of resorption, resulting in net bone loss. A greater imbalance develops in some people than in others and they are the ones who will suffer from osteoporosis, especially if they began with relatively low bone mass in middle age. This variation is to a large extent genetically determined, but lifestyle factors also contribute, including smoking, lack of exercise, low dietary calcium intake and, in the elderly, lack of vitamin D. Individuals who are small and thin are at greater risk because of their low bone mass compared with heavier individuals. Women who had an early menopause, or whose menstrual periods failed when they were young perhaps due to anorexia, are also at increased risk because the skeleton has had more prolonged exposure to a low oestrogen level. Although the process of resorption and formation is at the root of the osteoporotic condition, it is nevertheless a useful process which ensures that bone can repair minor damage and remodel itself in response to changing mechanical loads. It means that bone can respond positively to exercise and to drug treatments. Most of the effective drugs, such as bisphosphonates and hormone replacement therapy (HRT), act by slowing down resorption and therefore slowing the rate of loss of bone or tipping the balance in favour of formation.

The sites most commonly affected by osteoporosis are the wrist, the vertebrae in the spine, and the top of the femur (the hip). Vertebral fractures lead to collapse of the vertebrae which results in substantial loss of height or marked curvature of the spine (the Dowager's hump) and sometimes severe pain. Hip fractures occurring in the elderly in Britain cost the NHS nearly £1 billion in 1997 and the fracture rate has been rising faster than the increase in the number of elderly people in the population. The mortality rate following hip fracture is high and survivors usually suffer loss of independence and mobility. Both of these manifestations of osteoporosis were considered to be part of the normal ageing process until the middle of the twentieth century, and it was not until 1986 that the National Osteoporosis Society was established to provide support for sufferers, and advice and reliable information about the disease, which are still not widely available.

The osteoporotic condition develops slowly until so much bone has been lost that a threshold of vulnerability is reached and irreversible damage is likely. Preventative strategies are needed before this fragile state is reached. HRT is particularly useful for preventing post-menopausal loss in potentially vulnerable women. Adequate dietary calcium is essential. Dairy products such as cheese, yoghurt, and milk are rich in calcium. A pint of skimmed milk contains 700 mg which is the daily intake recommended in Britain. Smoking should be avoided, including passive smoking: it is known to interfere with the effect of oestrogen on bone. Excessive amounts of alcohol or caffeine (in tea, coffee, and coke) are also associated with a higher risk of osteoporosis.

The natural stimulus for bone to maintain its functional strength is the loading which results from gravitational forces and the tensions exerted by muscular activity. Astronauts lose bone while floating in space and so do patients who are confined to bed for long periods. Conversely, physically active people have higher bone mineral density compared with those who are sedentary. Exercise therefore has a role in reducing the long-term risk of osteoporotic fracture. The most effective exercise provides a regular series of varied short sharp loads to the sites which are most vulnerable for fracture. Brief exposure such as running up and down stairs a few times each day may be enough. Intermittent jogging (‘scouts' pace’) is useful, and so is weight-training, provided that over 70% of personal maximum effort is used in lifting slowly with a few repetitions. Research is still ongoing to find the best prescriptions. Improvements can probably occur at any age, but the increases appear to be largest before adolescence, and in later life vigorous exercise is obviously only safe for those who still have a robust skeleton. Bone changes slowly, improvements take months, and if the exercise is discontinued they are gradually lost again. In older people moderate exercise may prevent further loss of bone, and since fracture risk is only likely when bone density has fallen below a threshold value, maintenance is useful.

— Joan Bassey

Bibliography

  • The National Osteoporosis Society publishes booklets. Helpline 01761 471771

See also bone; hormone replacement therapy; menopause.

 
Food and Nutrition: osteoporosis
Top

Degeneration of the bones with advancing age due to loss of bone mineral and protein as a result of decreased secretion of hormones (oestrogens in women and testosterone in men). A high calcium intake in early life may be beneficial, since this may result in greater bone density at maturity.

 
Food and Fitness: osteoporosis
Top

brittle bone disease

A group of diseases characterized by a reduction in bone mass due to bone reabsorption outpacing bone deposition. The disease is usually associated with loss of weight. Other symptoms include feelings of lassitude, bone pains, and acute back pain. However, the most harmful effect of the disease is that bone becomes porous, brittle, and inclined to fracture. Over 250 000 Americans, most of them elderly, fall and break their hips each year, resulting in a $10 billion medical bill. Worldwide, the disease affects 1.7 million people each year. The number is expected to grow to over 6 million a year by 2050. A quarter of these people are expected to die within six months because of complications, usually linked to hip fractures.

Osteoporosis is an age-related disease, primarily affecting post-menopausal women, although it can occur much earlier in life (figure 47). There is always some degree of bone weakening with age, but insufficient exercise and a low calcium diet (especially in early life) may exacerbate this. Excessive exercising and weight-loss dieting are also linked with development of the disease. Development of the disease may be determined to some extent by a single gene. A gene affecting Vitamin D metabolism has been found in Australians which may be responsible for more than 75 per cent of the genetic variation in their bone density. If this gene occurs in a broader population, it may not be long before genetic screening can be used to identify those who are predisposed to the disease, so that preventative measures can be taken.

Figure 47 Osteoporosis. Images such as these have been used by the National Osteoporosis Society (UK) to heighten awareness and to encourage women to take preventative measures
Figure 47 Osteoporosis. Images such as these have been used by the National Osteoporosis Society (UK) to heighten awareness and to encourage women to take preventative measures


Physical exercise reduces the risk of osteoporosis. Moderate weight-bearing exercises, such as leisurely cycling, dancing, walking, and tennis, stimulate the deposition of calcium, strengthen bones, and reduce the risk of osteoporosis. However, young people benefit most from exercise; strong and healthy bones are more easily established in adolescents and young adults. A modest amount of jumping (as little as 50 jumps a day) can increase the density of hips in premenopausal women by as much as 3 per cent. Although exercise may offer some protection against acquiring the disease, those already suffering from osteoporosis should avoid contact sports and exercise that put undue stress on bones and joints. In particular, flexion exercises of the spine (e.g. sit ups) should be avoided because of the risk of vertebral fractures. Swimming is an especially good exercise for those with the disease.

Slightly overweight post-menopausal women are less likely to suffer from brittle bones than slim women. Possible reasons are that fat acts as a protective cushion; bones of plump women may be heavier and stronger; and the extra fat of plumper women enables them to produce more oestrogen which offers some protection against demineralization of bones.

A diet that includes a good intake of calcium-rich food (e.g. milk, yogurt, and cheese) may help prevent and minimize problems associated with this disease. It appears that it is particularly important for pre-menopausal women to have adequate calcium intakes so that they can achieve maximum peak bone densities. At present, the UK Reference Nutrient Intake is thought by The National Osteoporosis Society (UK) to be too low. They recommend the following calcium intakes:
• children 7-12 years800 mg per day
• teenagers/adults1000 mg per day
• women over 45 (not on HRT)1500 mg per day
• women over 45 (on HRT)1000 mg per day
• pregnant and lactating teenagers1500 mg per day
• pregnant and lactating adults1200 mg per day
• men over 45 years1500 mg per day


Some doctors believe that the best way to prevent osteoporosis in post-menopausal women is hormone replacement therapy (see menopause), but this treatment is not suitable for all women. See also amenorrhoea and parathyroid hormone.

 
Dental Dictionary: osteoporosis
Top
(os′tē ōpôrō′sis)
n

An enlargement of the soft marrow and haversian spaces resulting from a decreased rate of formation of the hard bone matrix. With the exception of immobilized parts, it is a systemic disorder that occurs in advanced age (senile osteoporosis), during ACTH and cortisone therapy, during and after menopause, in limited physical activity, in Cushing’s syndrome, during malnutrition, and in other disorders of matrix formation such as hyperadrenalism, hyperthyroidism, vitamin C deficiencies, and deficiency of androgenic steroids. See also atrophy, bone and bone rarefaction.

 

Definition

The word osteoporosis literally means porous bones. It occurs when bones lose an excessive amount of their protein and mineral content, particularly calcium. Over time, bone mass, and therefore bone strength, is decreased. As a result, the bones become fragile and break easily. Even a sneeze or a sudden movement may be enough to break a bone in someone with severe osteoporosis.

Description

Osteoporosis is a serious public health problem. Some 28 million people in the United States are affected by this potentially debilitating disease, which is responsible for 1.5 million fractures (broken bones) annually. These fractures, which are often the first sign of the disease, can affect any bone, but the most common locations are the hip, spine, and wrist. Breaks in the hip and spine are of special concern because they almost always require hospitalization and major surgery; and may lead to other serious consequences, including permanent disability and even death.

To understand osteoporosis, it is helpful to understand the basics of bone formation. Bone is living tissue that's constantly being renewed in a two-stage process (resorption and formation) that occurs throughout life. In the resorption stage, old bone is broken down and removed by cells called osteoclasts. In the formation stage, cells called osteoblasts build new bone to replace the old. During childhood and early adulthood, more bone is produced than removed, reaching its maximum mass and strength by the mid-30s. After that, bone is lost at a faster pace than it's formed, so the amount of bone in the skeleton begins to slowly decline. Most cases of osteoporosis occur as an acceleration of this normal aging process. That is referred to as primary osteoporosis. The condition can also be caused by other disease processes or prolonged use of certain medications that result in bone loss; if so, it is called secondary osteoporosis.

Osteoporosis occurs most often in older people, especially in women after menopause. It affects nearly half of all adults, men and women, over the age of 75. Women, however, are five times more likely than men to develop the disease. They have smaller, thinner bones than men to begin with, and they lose bone mass more rapidly after menopause (usually around age 50), when they stop producing a bone-protecting hormone called estrogen. In the five to seven years following menopause, women can lose about 20% of their bone mass. By age 65 or 70, though, men and women lose bone mass at the same rate.

As an increasing number of men live longer, health professionals are increasingly aware that osteoporosis is an important health issue for men as well. In fact, men account for about 20% of all spinal fractures and up to 30% of all hip fractures due to osteoporosis.

Causes & Symptoms

A number of factors increase the risk of developing osteoporosis. They include:

  • Age. Osteoporosis is more likely as people grow older and their bones lose strength.
  • Sex. Women are more likely to have osteoporosis because they start out with less bone. They also lose bone tissue more rapidly as they age. While women commonly lose 30%–50% of their bone mass over their lifetimes, men lose only 20%–33% of theirs.
  • Race. Caucasian and Asian women are most at risk for the disease, but African American and Hispanic women can get it too.
  • Body type. Women with small bones or thin frames are more liable to develop osteoporosis.
  • Early menopause. Women who begin menopause early because of heredity, surgery, or lots of physical exercise may lose large amounts of bone tissue early in life. Such conditions as anorexia and bulimia may also lead to early menopause and osteoporosis.
  • Lifestyle. People who smoke or drink too much, or do not get enough exercise, have an increased chance of getting osteoporosis.
  • Medications. Certain prescription medications may speed up the loss of bone. These drugs include methotrexate, cimetidine, corticosteroids, and heparin.
  • Diet. Adults who do not get enough calcium or protein may be more likely to have osteoporosis. People who constantly diet are more prone to the disease.

Osteoporosis is often called the silent disease, because bone loss occurs without symptoms. People often don't know they have the disease until a bone breaks, frequently in a minor fall that wouldn't normally cause a fracture. A common occurrence is compression fractures of the spine. These can happen even after a seemingly normal activity, such as bending or twisting to pick up a light object. The fractures can cause severe back pain, but sometimes they go unnoticed. Either way, the vertebrae collapse down on themselves, and the person actually loses height. The hunchback appearance of many elderly women, sometimes called dowager's hump or widow's hump, is due to the effect of osteoporosis on the vertebrae.

Diagnosis

Certain types of doctors may have more training and experience than others in diagnosing and treating people with osteoporosis. These include a geriatrician, who specializes in treating the aged; an endocrinologist, who specializes in treating diseases of the body's endocrine system (glands and hormones); and an orthopedic surgeon, who treats fractures, such as those caused by osteoporosis.

Before making a diagnosis of osteoporosis, the doctor usually takes a complete medical history, conducts a physical examination, and orders x rays, as well as blood and urine tests, to rule out other diseases that cause loss of bone mass. The doctor may also recommend a bone density test. This is the only way to know for certain if osteoporosis is present. It can also show how far the disease has progressed.

Several diagnostic tools are available to measure the density of a bone. The ordinary x ray is one, though it's the least accurate for early detection of osteoporosis, because it doesn't reveal bone loss until the disease is advanced and most of the damage has already been done. Two other tools that are more likely to catch osteoporosis at an early stage are computed tomography scans (CT scans) and machines called densitometers, which are designed specifically to measure bone density.

The CT scan, which takes a large number of x rays of the same spot from different angles, is an accurate test, but uses higher levels of radiation than other methods. The most accurate and advanced of the densitometers uses a technique called DEXA (dual energy x-ray absorptiometry). With the DEXA scan, a double x-ray beam takes pictures of the spine, hip, or entire body. It takes about 20 minutes to do, is painless, and exposes the patient to only a small amount of radiation—about 1/50 that of a chest x ray.

In late 2001, Medicare began reimbursing for a test that measures bone resorption, an important measure for tracking a patient's response to osteoporosis therapy. The relatively inexpensive test measures a baseline amount, then compares amounts from later tests to track progress. The test consists of simple urine collection.

People should talk to their doctors about their risk factors for osteoporosis and if and when to have a bone density test. Ideally, women should have bone density measured at menopause and periodically afterward, depending on the condition of their bones. Men should be tested around age 65. Men and women with additional risk factors, such as those who take certain medications, may need to be tested earlier.

Treatment

Alternative treatments for osteoporosis focus on maintaining or building strong bones. They include nutritional and herbal therapies and homeopathy.

Nutritional Therapy

A healthful diet low in fats and animal products and containing whole grains, fresh fruits and vegetables, and calcium-rich foods (such as dairy products, dark-green leafy vegetables, sardines, salmon, and almonds), along with nutritional supplements (such as calcium, magnesium, and vitamin D) are important components of nutritional approaches to treating this disease.

Women should also eat more soy products such as tofu, soy burgers, or miso. Soy beans contain a substance called isoflavones which have estrogen-like activity. Isoflavones may help to increase bone density, alleviate hot flashes and other menopausal symptoms, lower the risk of cancer, and even reduce the risk of heart attacks. Natural hormone therapy, such as the use of soy products, is a safer alternative to synthetic estrogenic hormones, which may increase the risk of breast cancer.

In addition, women should avoid foods that may accelerate bone loss. They should avoid having too much salt in their diet, not only because salt raises the blood pressure but also because it may contribute to osteoporosis. They should also cut down on coffee, caffeinated sodas, and alcohol. High consumption of these beverages, studies have shown, are associated with accelerated drop in bone density and increase risk of bone fracture in old age. Caffeinated sodas are especially bad for the bones because in addition to containing caffeine, they also have high amounts of phosphoric acid. Phosphoric acid increases bone resorption, thus decreasing bone density.

Herbal Supplements

Herbal supplements for osteoporosis emphasize such calcium-containing plants as horsetail (Equisetum arvense), oat straw (Avena sativa), alfalfa (Medicago sativa), licorice (Glycyrrhiza glabra), marsh mallow (Althaea officinalis), and sourdock (Rumex crispus). There are, however, few data from clinical trials to support the use of these herbs.

Homeopathy

Homeopathic remedies for osteoporosis focus on treatments believed to help the body absorb calcium. These remedies may include such substances as Calcarea carbonica (calcium carbonate) or Silica (flint). Again, there are few data other than isolated case reports regarding the effectiveness of these remedies.

Allopathic Treatments

There are a number of good treatments for primary osteoporosis, most of them medications. For people with secondary osteoporosis, treatment may focus on curing the underlying disease.

Drugs

For most women who've gone through menopause, the best treatment for osteoporosis is hormone replacement therapy (HRT), also called estrogen replacement therapy. In addition to alleviating hot flashes, synthetic estrogens protect women against heart disease and they help to relieve and prevent osteoporosis. HRT increases a woman's supply of estrogen, which helps build new bone while preventing further bone loss.

Some women, however, do not want to take hormones because they have been linked to an increased risk of breast or uterine cancer. Other studies suggest that the risk is due to increasing age. Whether or not a woman takes hormones is a decision she should make carefully with her doctor. Most women take estrogen along with a synthetic form of progesterone, another female hormone. The combination helps protect against cancer of the uterus.

For people who can't or decide not to take estrogen, two other medications can be good choices. These are alendronate and calcitonin. Alendronate and calcitonin both stop bone loss, help build bone, and decrease fracture risk by as much as 50%. Alendronate (sold under the name Fosamax) is the first nonhormonal medication for osteoporosis ever approved by the FDA. It attaches itself to bone that's been targeted by bone-eating osteoclasts. It protects the bone from these cells. Osteoclasts help your body break down old bone tissue.

Calcitonin is a hormone that's been used as an injection for many years. A new version is on the market as a nasal spray. It too slows down bone-eating osteoclasts. Side effects of these drugs are minimal, but calcitonin builds bone by only 1.5% a year. Fosamax (alendronic acid) has proven safe in very large multi-year studies, and is now indicated for treatment of osteoporosis in most men. Several medications under study include other biphosphonates that slow bone breakdown (like alendronate), sodium fluoride, vitamin D metabolites, and selective estrogen receptor modulators.

Surgery

Unfortunately, much of the treatment for osteoporosis is for fractures that result from advanced stages of the disease. For complicated fractures, such as broken hips, hospitalization and a surgical procedure are required. In hip replacement surgery, the broken hip is removed and replaced with a new hip made of plastic, or metal and plastic. Despite often-successful surgeries, a large percentage of those who survive are unable to return to their previous level of activity, and many end up moving from self-care to a supervised living situation or nursing home. That's why prevention, getting early treatment, and taking steps to reduce bone loss are vital.

Expected Results

There is no cure for osteoporosis, but it can be controlled. Most people who have osteoporosis fare well once they get treatment. The medicines available now build bone, protect against bone loss, and halt the progress of this disease.

Prevention

Building strong bones, especially before the age of 35, and maintaining a healthy lifestyle are the best ways of preventing osteoporosis. To build as much bone mass as early as possible in life, and to help slow the rate of bone loss later in life:

Get Calcium in Foods

Experts recommend 1,500 milligrams (mg) of calcium per day for adolescents, pregnant or breast-feeding women, older adults (over 65), and postmenopausal women not using hormone replacement therapy. All others should get 1,000 mg per day. Foods are the best source for this important mineral. Milk, cheese, and yogurt have the highest amounts. Other foods that are high in calcium are green leafy vegetables, tofu, shellfish, Brazil nuts, sardines, and almonds.

Take Calcium Supplements

Many people, especially those who don't like or can't eat dairy foods, don't get enough calcium in their diets and may need to take a calcium supplement. Supplements should be taken with meals and accompanied by six to eight glasses of water a day.

Get Vitamin D

Vitamin D helps the body absorb calcium. People can get vitamin D from sunshine with a quick (15–20 minute) walk each day or from foods such as liver, fish oil, and vitamin D fortified milk. During the winter months it may be necessary to take supplements. Four hundred mg daily is usually the recommended amount.

Avoid Smoking and Alcohol

Smoking reduces bone mass, as does heavy drinking. To reduce risk, do not smoke; and limit alcoholic drinks to no more than two per day. An alcoholic drink is 1.5 ounces of hard liquor, 12 ounces of beer, or 5 ounces of wine.

Exercise Regularly

Exercising regularly builds and strengthens bones. Weight-bearing exercises, in which bones and muscles work against gravity, are best. These include aerobics, dancing, jogging, stair climbing, tennis, walking, and lifting weights. People who have osteoporosis may want to attempt gentle exercise, such as walking, rather than jogging or fast-paced aerobics, which increase the chance of falling. Try to exercise three to four times per week for 20–30 minutes each time.

Resources

Books

Brown, Susan E. Better Bones, Better Body: A Comprehensive Self-Help Program for Preventing, Halting and Overcoming Osteoporosis. New Canaan, CT: Keats Publishing, 1996.

The Burton Goldberg Group. Alternative Medicine: The Definitive Guide. Fife, WA: Future Medicine Publishing, 1995.

Hammond, Christopher. The Complete Family Guide to Homeopathy: An Illustrated Encyclopedia of Safe and Effective Remedies. New York: Penguin Books, 1995.

Murray, Michael and Joseph Pizzorno. Encyclopedia of Natural Medicine. Rocklin, CA: Prima Health, 1998.

Notelovits, Morris, with Marsha Ware and Diana Tonnessen. Stand Tall! Every Woman's Guide to Preventing and Treating Osteoporosis, 2nd ed. Gainesville, FL: Triad Publishing Co., 1998.

Zand, Janet, Allan N. Spreen, and James B. LaValle. Smart Medicine for Healthier Living: A Practical A-to-Z Reference to Natural and Conventional Treatments for Adults. Garden City Park, NY: Avery Publishing Group, 1999.

Periodicals

"Brittle bone relief for men." Chemist and Druggist (December 15, 2001):25.

"Test Gains Mandatory National Medicare Coverage." Health and Medicine Week (December 31, 2001):29.

Organizations

Arthritis Foundation. 1330 W. Peachtree St. PO Box 7669. Atlanta, GA 30357-0669. (800) 283-7800. http://www.arthritis.org.

National Osteoporosis Foundation. Suite 500, 1150 17th Street, NW. Washington, DC 20036-4603. (800) 223-9994. http://www.nof.org.

[Article by: Mai Tran; Teresa G. Odle]

 

Osteoporosis (literally "porous bone") is a condition characterized by bone fragility and fracturing. The World Health Organization (WHO) defines osteoporosis as a 25 percent reduction of bone mineral density (BMD) compared to that of a healthy young adult female.

Eight million Americans have osteoporosis, and over 20 million have osteopenia (thin bones, or a loss of 10 to 25% of bone mineral density). Osteoporosis is most prevalent in Caucasians, less prevalent in Hispanics, and least prevalent in African Americans. Key predisposing factors are early menopause and a family history of osteoporosis. Other medical, psychological, and social factors may also contribute to the condition.

Osteoporosis commonly leads to fractures. Medical, social, and environmental factors that predispose people to osteoporosis-related fractures include impairment of hearing, vision, balance and cognition; debilitating illnesses; medications; postoperative conditions; and unsafe environments. In the United States, one of three females over age sixty-five will have at least one vertebral fracture. The ratio of female to male fractures of a hip is 2.5 to one. Two hundred and fifty thousand hip or wrist fractures and 500,000 vertebral fractures occur annually in the United States. Up to 15 percent of hip fractures will result in death within one year, and one of three survivors become long-term nursing home residents. The annual cost of osteoporosis in the United States is estimated to be as high as $18 million and is projected to reach $240 million by the year 2040.

There are several methods to measure bone mineral density for osteoporosis detection. The most precise is dual energy X-ray absorptiometry (DXA) of the hip. Blood and urine tests for bone resorption and formation are also used to help measure the response to therapy.

The four components of treatment are nutrition, medication, exercise, and safety. Nutritional factors are particularly important during childhood and adolescence when the bones are growing. Key components are calcium and vitamin D, supplemented by magnesium; and vitamins C and K for individuals with chronic diarrhea or on a low-vegetable diet.

Hormonal therapies—estrogens for postmenopausal females and testosterone for hypogonadal males—are widely utilized. Estrogens may be contraindicated by breast or uterine cancer or by susceptibility to vascular clotting, and prostatic disorders may preclude the use of testosterone. Bisphosphonates are potent antiresorptive drugs that can yield reductions in hip and vertebral fracturing. Use of calcitonin, another antiresorptive drug, has also shown reductions in vertebral fracturing.

Exercise and safety are essential components of fracture prevention. Vigorous weight-bearing activities are beneficial but not feasible for the elderly or infirm. Walking has not proved efficacious. Resistive exercises increase the muscle strength and bone mineral density essential to fracture prevention. Balance–enhancing activities such as dancing, careful attention to minimizing hazards in the home and work environments, and selective use of padded hip protectors for the aged and infirm all help reduce the risk of osteoporosis-related fractures.

Osteoporosis is a major and growing public health concern. Appropriate screening to identify those who are susceptible, accurate diagnosis of osteoporosis and related disorders, and prompt institution and monitoring of appropriate therapies are all essential to minimize the risks of fracture and the attendant mortality and morbidity.

(SEE ALSO: Hip Fractures)

Bibliography

Melton, L. J., III (2000). "Perspective: Who Has Osteoporosis? A Conflict Between Clinical and Public Health Perspectives." Journal of Bone and Mineral Research 15(12):2309–2314.

Scheiber, L. B., II, and Torregrosa, L. (1988). "Evaluation and Treatment of Postmenopausal Osteoporosis." Seminars in Arthritis and Rheumatism 27(4):245–261.

Swezey, R. L. (2000). "Osteoporosis: Diagnosis, Pharmacological, and Rehabilitation Therapies." Critical Reviews in Physical and Rehabilitation Medicine 12(3):229–269.

Youm, T.; Koval, K. J.; and Zuckerman, J. D. (1999). "The Economic Impact of Geriatric Hip Fractures." American Journal of Orthopedics 28(7):423–428.

— ROBERT L. SWEZEY



 

Generalized loss of bone density, causing skeletal weakness. Around age 40, the rate of bone resorption in humans starts to exceed the rate of bone formation. Women experience accelerated bone loss after menopause, when the estrogen level decreases. When the amount of bone falls below a certain threshold, fractures occur with little or no trauma. Prevention begins with adequate calcium intake in youth, when bone mass is built, and then throughout life. Weight-bearing exercise and vitamin D are important at all ages. Medications can inhibit bone resorption or prevent bone loss in patients who are at risk for developing osteoporosis.

For more information on osteoporosis, visit Britannica.com.

 
Sports Science and Medicine: osteoporosis
Top

brittle bone disease

A group of diseases characterized by decreased bone mineral content that increases bone porosity, and causes them to become more brittle and more inclined to fracture. Osteoporosis is an age-related disease, which primarily affects post-menopausal women. Physical exercise when young can reduce the risk of developing the disease in later life. Moderate weight-bearing exercise (e.g. dancing, walking, and tennis) stimulates the deposition of calcium, strengthening bones. Women with osteoporosis should avoid contact sports and high-impact exercise which puts undue stress on bones and joints. Sit-ups are also harmful because of the stress they impose on vertebrae. A premenopausal diet rich in calcium and vitamin D also reduces the risk of osteoporosis.

 
Columbia Encyclopedia: osteoporosis
Top
osteoporosis (ŏs'tēō'pərō'sĭs) , disorder in which the normal replenishment of old bone tissue is severely disrupted, resulting in weakened bones and increased risk of fracture; osteopenia results when bone-mass loss is significant but not as severe as in osteoporosis. Although osteoporosis can occur in anyone, it is most common in thin white women after menopause.

Bone mass is typically at its greatest during a person's mid-twenties; after that point there is a gradual reduction in bone mass as bone is not replenished as quickly as it is resorbed. In postmenopausal women the production of estrogen, a hormone that helps maintain the levels of calcium and other minerals necessary for normal bone regeneration, drops off dramatically, resulting in an accelerated loss of bone mass of up to 3% per year over a period of five to seven years. Smoking, excessive alcohol consumption, and a sedentary lifestyle increase the risk of bone-mass loss; a diet high in protein and sodium also speed calcium loss. The disorder also has a genetic component. A vitamin D receptor gene that affects calcium uptake and bone density has been identified, and the different forms of this gene appear to correlate with differences in levels of bone density among osteoporosis patients.

Osteoporosis has no early symptoms and is usually not diagnosed until a fracture occurs, typically in the hip, spine, or wrist. A diagnostic bone density test is thus recommended as a preventive measure for women at high risk. Treatment can slow the process or prevent further bone loss. Estrogen replacement therapy for postmenopausal women is effective but has potential side effects. Calcitonin, a thyroid hormone, is administered in some cases. Nonhormonal drugs for the treatment of osteoporosis include alendronate (Fosamax) and risedronate (Actonel), bisphosphonates that decrease bone resorption, and raloxifene (Evista), a selective estrogen receptor modulator that can increase bone mineral density. Teriparatide (Forteo), which consists of the biologically active region of human parathyroid hormone, stimulates the activity of osteoblasts, the specialized cells that form new bone. Dietary and supplemental calcium and vitamin D are usually recommended for people at risk, but a seven-year study of more than 36,000 women over 50 that was released in 2006 found that supplements conferred little benefit. Exercise, including weight training, has been found to strengthen bones directly and to improve muscle strength and balance and thus minimize the chance of falls.

Bibliography

See M. Hegsted, Advances in Nutrition Research, Vol. 9: Nutrition and Osteoporosis (1994).


 
Health Dictionary: osteoporosis
Top
(os-tee-oh-puh-roh-sis)

A softening of the bones that gradually increases and makes them more fragile. It is caused by the gradual loss of the mineral calcium, which helps make bones hard. Osteoporosis occurs most often in elderly women.

  • Many experts now believe that osteoporosis can be prevented through regular exercise, mineral supplements, and a diet high in calcium.

  •  
    Veterinary Dictionary: osteoporosis
    Top

    A pathological loss of bone but the remaining bone is structurally normal. There is an imbalance in bone formation and resorption in favor of resorption. Bone becomes light and porous and fragile so that it fractures easily. It is associated with general undernutrition rather than specific nutritional deficiencies. Other causative factors are disuse, senility, lactation, weightlessness.

    • disuse o. — that occurring when the normal laying down of bone is slowed because of lack of the normal stimulus of functional stress on the bone.
    • post-traumatic o. — loss of bone substance after an injury in which there is nerve damage, sometimes due to decreased blood supply caused by the neurogenic insult, or to disuse secondary to pain.
     
    Wikipedia: Osteoporosis
    Top
    Osteoporosis
    Classification and external resources
    ICD-10 M80.-M82.
    ICD-9 733.0
    OMIM 166710
    DiseasesDB 9385
    MedlinePlus 000360
    eMedicine med/1693  ped/1683 pmr/94 pmr/95
    MeSH D010024

    Osteoporosis is a disease of bone that leads to an increased risk of fracture. In osteoporosis the bone mineral density (BMD) is reduced, bone microarchitecture is disrupted, and the amount and variety of non-collagenous proteins in bone is altered. Osteoporosis is defined by the World Health Organization (WHO) in women as a bone mineral density 2.5 standard deviations below peak bone mass (20-year-old healthy female average) as measured by DXA; the term "established osteoporosis" includes the presence of a fragility fracture.[1] Osteoporosis is most common in women after menopause, when it is called postmenopausal osteoporosis, but may also develop in men, and may occur in anyone in the presence of particular hormonal disorders and other chronic diseases or as a result of medications, specifically glucocorticoids, when the disease is called steroid- or glucocorticoid-induced osteoporosis (SIOP or GIOP). Given its influence is the risk of fragility fracture, osteoporosis may significantly affect life expectancy and quality of life.

    Osteoporosis can be prevented with lifestyle changes and sometimes medication; in people with osteoporosis, treatment may involve both. Lifestyle change includes preventing falls and exercise; medication includes calcium, vitamin D, bisphosphonates and several others. Fall-prevention advice includes exercise to tone deambulatory muscles, proprioception-improvement exercises; equilibrium therapies may be included. Exercise with its anabolic effect, may at the same time stop or reverse osteoporosis.

    Contents

    Pathogenesis

    The underlying mechanism in all cases of osteoporosis is an imbalance between bone resorption and bone formation. In normal bone, there is constant matrix remodeling of bone; up to 10% of all bone mass may be undergoing remodeling at any point in time. The process takes place in bone multicellular units (BMUs) as first described by Frost in 1963.[2] Bone is resorbed by osteoclast cells (which derive from the bone marrow), after which new bone is deposited by osteoblast cells. [3]

    The three main mechanisms by which osteoporosis develops are an inadequate peak bone mass (the skeleton develops insufficient mass and strength during growth), excessive bone resorption and inadequate formation of new bone during remodeling. An interplay of these three mechanisms underlies the development of fragile bone tissue.[3] Hormonal factors strongly determine the rate of bone resorption; lack of estrogen (e.g. as a result of menopause) increases bone resorption as well as decreasing the deposition of new bone that normally takes place in weight-bearing bones. The amount of estrogen needed to suppress this process is lower than that normally needed to stimulate the uterus and breast gland. The α-form of the estrogen receptor appears to be the most important in regulating bone turnover.[3] In addition to estrogen, calcium metabolism plays a significant role in bone turnover, and deficiency of calcium and vitamin D leads to impaired bone deposition; in addition, the parathyroid glands react to low calcium levels by secreting parathyroid hormone (parathormone, PTH), which increases bone resorption to ensure sufficient calcium in the blood. The role of calcitonin, a hormone generated by the thyroid that increases bone deposition, is less clear and probably not as significant as that of PTH.[3]

    The activation of osteoclasts is regulated by various molecular signals, of which RANKL (receptor activator for nuclear factor κB ligand) is one of best studied. This molecule is produced by osteoblasts and other cells (e.g. lymphocytes), and stimulates RANK (receptor activator of nuclear factor κB). Osteoprotegerin (OPG) binds RANKL before it has an opportunity to bind to RANK, and hence suppresses its ability to increase bone resorption. RANKL, RANK and OPG are closely related to tumor necrosis factor and its receptors. The role of the wnt signalling pathway is recognized but less well understood. Local production of eicosanoids and interleukins is thought to participate in the regulation of bone turnover, and excess or reduced production of these mediators may underlie the development of osteoporosis.[3]

    Trabecular bone is the sponge-like bone in the ends of long bones and vertebrae. Cortical bone is the hard outer shell of bones and the middle of long bones. Because osteoblasts and osteoclasts inhabit the surface of bones, trabecular bone is more active, more subject to bone turnover, to remodeling. Not only is bone density decreased, but the microarchitecture of bone is disrupted. The weaker spicules of trabecular bone break ("microcracks"), and are replaced by weaker bone. Common osteoporotic fracture sites, the wrist, the hip and the spine, have a relatively high trabecular bone to cortical bone ratio. These areas rely on trabecular bone for strength, and therefore the intense remodeling causes these areas to degenerate most when the remodeling is imbalanced.[citation needed]

    Signs and symptoms

    Osteoporosis itself has no specific symptoms; its main consequence is the increased risk of bone fractures. Osteoporotic fractures are those that occur in situations where healthy people would not normally break a bone; they are therefore regarded as fragility fractures. Typical fragility fractures occur in the vertebral column, rib, hip and wrist.

    Fractures

    The symptoms of a vertebral collapse ("compression fracture") are sudden back pain, often with radiculopathic pain (shooting pain due to nerve compression) and rarely with spinal cord compression or cauda equina syndrome. Multiple vertebral fractures lead to a stooped posture, loss of height, and chronic pain with resultant reduction in mobility.[4]

    Fractures of the long bones acutely impair mobility and may require surgery. Hip fracture, in particular, usually requires prompt surgery, as there are serious risks associated with a hip fracture, such as deep vein thrombosis and a pulmonary embolism, and increased mortality.

    Falls risk

    The increased risk of falling associated with aging leads to fractures of the wrist, spine and hip. The risk of falling, in turn, is increased by impaired eyesight due to any cause (e.g. glaucoma, macular degeneration), balance disorder, movement disorders (e.g. Parkinson's disease), dementia, and sarcopenia (age-related loss of skeletal muscle). Collapse (transient loss of postural tone with or without loss of consciousness) leads to a significant risk of falls; causes of syncope are manifold but may include cardiac arrhythmias (irregular heart beat), vasovagal syncope, orthostatic hypotension (abnormal drop in blood pressure on standing up) and seizures. Removal of obstacles and loose carpets in the living environment may substantially reduce falls. Those with previous falls, as well as those with a gait or balance disorder, are most at risk.[5]

    Risk factors

    Risk factors for osteoporotic fracture can be split between non-modifiable and (potentially) modifiable. In addition, there are specific diseases and disorders in which osteoporosis is a recognized complication. Medication use is theoretically modifiable, although in many cases the use of medication that increases osteoporosis risk is unavoidable.

    Nonmodifiable

    The most important risk factors for osteoporosis are advanced age (in both men and women) and female sex; estrogen deficiency following menopause is correlated with a rapid reduction in bone mineral density, while in men a decrease in testosterone levels has a comparable (but less pronounced) effect. While osteoporosis occurs in people from all ethnic groups, European or Asian ancestry predisposes for osteoporosis.[6] Those with a family history of fracture or osteoporosis are at an increased risk; the heritability of the fracture as well as low bone mineral density are relatively high, ranging from 25 to 80 percent. There are at least 30 genes associated with the development of osteoporosis.[3] Those who have already had a fracture are at least twice as likely to have another fracture compared to someone of the same age and sex.[7]

    Potentially modifiable

    • Excess alcohol - small amounts of alcohol do not increase osteoporosis risk and may even be beneficial, but chronic heavy drinking (alcohol intake greater than 2 units/day),[8] especially at a younger age, increases risk significantly.[9]
    • Vitamin D deficiency[10] - low circulating Vitamin D is common among the elderly worldwide.[11] Mild vitamin D insufficiency is associated with increased Parathyroid Hormone (PTH) production. [11] PTH increases bone resorption, leading to bone loss. A positive association exists between serum 1,25-dihydroxycholecalciferol levels and bone mineral density, while PTH is negatively associated with bone mineral density.[11]
    • Tobacco smoking - tobacco smoking inhibits the activity of osteoblasts, and is an independent risk factor for osteoporosis.[8][12] Smoking also results in increased breakdown of exogenous estrogen, lower body weight and earlier menopause, all of which contribute to lower bone mineral density.[11]
    • Low body mass index - being overweight protects against osteoporosis, either by increasing load or through the hormone leptin.[13]
    • Malnutrition - low dietary calcium intake, low dietary intake of vitamins K and C[10] Also low protein intake is associated with lower peak bone mass during adolescence and lower bone mineral density in elderly populations.[11]
    • Physical inactivity - bone remodeling occurs in response to physical stress. Weight bearing exercise can increase peak bone mass achieved in adolescence.[11] In adults, physical activity helps maintain bone mass, and can increase it by 1 or 2%.[citation needed] Conversely, physical inactivity can lead to significant bone loss.[11]
    • Excess physical activity - excessive exercise can lead to constant damages to the bones which can cause exhaustion of the structures as described above. There are numerous examples of marathon runners who developed severe osteoporosis later in life. In women, heavy exercise can lead to decreased estrogen levels, which predisposes to osteoporosis. In addition, intensive training without proper compensatory increased nutrition increases the risk.
    • Heavy metals - a strong association between cadmium, lead and bone disease has been established. Low level exposure to cadmium is associated with an increased loss of bone mineral density readily in both genders, leading to pain and increased risk of fractures, especially in the elderly and in females. Higher cadmium exposure results in osteomalacia (softening of the bone).[14]
    • Soft drinks - some studies indicate that soft drinks (many of which contain phosphoric acid) may increase risk of osteoporosis;[15] Others suggest soft drinks may displace calcium-containing drinks from the diet rather than directly causing osteoporosis.[16]
    • Caffeine – contrary to popular belief, there is no evidence linking caffeine to osteoporosis.[17]

    Diseases and disorders

    Many diseases and disorders have been associated with osteoporosis.[18] For some, the underlying mechanism influencing the bone metabolism is straight-forward, whereas for others the causes are multiple or unknown.

    Medication

    Certain medications have been associated with an increase in osteoporosis risk; only steroids and anticonvulsants are classically associated, but evidence is emerging with regard to other drugs.

    Diagnosis

    A scanner used to measure bone density with dual energy X-ray absorptiometry.

    The diagnosis of osteoporosis is made on measuring the bone mineral density (BMD). The most popular method is dual energy X-ray absorptiometry (DXA or DEXA). In addition to the detection of abnormal BMD, the diagnosis of osteoporosis requires investigations into potentially modifiable underlying causes; this may be done with blood tests and X-rays. Depending on the likelihood of an underlying problem, investigations for cancer with metastasis to the bone, multiple myeloma, Cushing's disease and other above mentioned causes may be performed.

    Dual energy X-ray absorptiometry

    Dual energy X-ray absorptiometry (DXA, formerly DEXA) is considered the gold standard for the diagnosis of osteoporosis. Osteoporosis is diagnosed when the bone mineral density is less than or equal to 2.5 standard deviations below that of a young adult reference population. This is translated as a T-score. The World Health Organization has established the following diagnostic guidelines:[1][11]

    • T-score -1.0 or greater is "normal"
    • T-score between -1.0 and -2.5 is "low bone mass" (or "osteopenia")
    • T-score -2.5 or below is osteoporosis

    When there has also been an osteoporotic fracture (also termed "low trauma-fracture" or "fragility fracture"), defined as one that occurs as a result of a fall from a standing height, the term "severe or established" osteoporosis is used.[1]

    The International Society for Clinical Densitometry takes the position that a diagnosis of osteoporosis in men under 50 years of age should not be made on the basis of densitometric criteria alone. It also states that for pre-menopausal women, Z-scores (comparison with age group rather than peak bone mass) rather than T-scores should be used, and that the diagnosis of osteoporosis in such women also should not be made on the basis of densitometric criteria alone.[28]

    Screening

    The U.S. Preventive Services Task Force (USPSTF) recommended in 2002 that all women 65 years of age or older should be screened with bone densitometry.[29] The Task Force recommends screening only those women ages 60 to 64 years of age who are at increased risk. The best risk factor for indicating increased risk is lower body weight (weight < 70 kg), with less evidence for smoking or family history. There was insufficient evidence to make recommendations about the optimal intervals for repeated screening and the appropriate age to stop screening. Clinical prediction rules are available to guide selection of women ages 60–64 for screening. The Osteoporosis Risk Assessment Instrument (ORAI) may be the most sensitive strategy[30]

    Regarding the screening of men, a cost-analysis study suggests that screening may be "cost-effective for men with a self-reported prior fracture beginning at age 65 years and for men 80 years and older with no prior fracture".[31] Also cost-effective is the screening of adult men from middle age on to detect any significant decrease in testosterone levels, say, below 300.

    Treatment

    There are several medications used to treat osteoporosis, depending on gender. Lifestyle changes are also an aspect of treatment.

    Medication

    Bisphosphonates are the main pharmacological measures for treatment. However, newer drugs have appeared in the 1990s, such as teriparatide and strontium ranelate.

    Bisphosphonates

    In confirmed osteoporosis, bisphosphonate drugs are the first-line treatment in women. The most often prescribed bisphosphonates are presently sodium alendronate (Fosamax) 10 mg a day or 70 mg once a week, risedronate (Actonel) 5 mg a day or 35 mg once a week and or ibandronate (Boniva) once a month.

    A 2007 manufacturer-supported study suggested that in patients who had suffered a low-impact hip fracture, annual infusion of 5 mg zoledronic acid reduced risk of any fracture by 35% (from 13.9 to 8.6%), vertebral fracture risk from 3.8% to 1.7% and non-vertebral fracture risk from 10.7% to 7.6%. This study also found a mortality benefit: after 1.9 years, 9.6% of the study group (as opposed to 13.3% of the control group) had died of any cause, indicating a mortality benefit of 28%.[32]

    Oral bisphosphonates are relatively poorly absorbed, and must therefore be taken on an empty stomach, with no food or drink to follow for the next 30 minutes. They are associated with esophagitis and are therefore sometimes poorly tolerated; weekly or monthly administration (depending on the preparation) decreases likelihood of esophagitis, and is now standard. Although intermittent dosing with the intravenous formulations such as zolendronate avoids oral tolerance problems, these agents are implicated at higher rates in a rare but unpleasant mouth disease called osteonecrosis of the jaw.[33] For this reason, oral bisphosphonate therapy is probably to be preferred, and prescribing advice now recommends any remedial dental work to be carried out prior to commencing treatment.[34]

    Teriparatide

    Recently, teriparatide (Forteo, recombinant parathyroid hormone residues 1–34) has been shown to be effective in osteoporosis. It acts like parathyroid hormone and stimulates osteoblasts, thus increasing their activity. It is used mostly for patients with established osteoporosis (who have already fractured), have particularly low BMD or several risk factors for fracture or cannot tolerate the oral bisphosphonates. It is given as a daily injection with the use of a pen-type injection device. Teriparatide is only licensed for treatment if bisphosphonates have failed or are contraindicated (however, this differs by country and is not required by the FDA in the USA. However, patients with previous radiation therapy, or Paget's disease, or young patients should avoid this medication).

    Strontium ranelate

    Oral strontium ranelate is an alternative oral treatment, belonging to a class of drugs called "dual action bone agents" (DABAs) by its manufacturer. It has proven efficacy, especially in the prevention of vertebral fracture.[35] In laboratory experiments, strontium ranelate was noted to stimulate the proliferation of osteoblasts, as well as inhibiting the proliferation of osteoclasts.

    Strontium ranelate is taken as a 2 g oral suspension daily, and is licenced for the treatment of osteoporosis to prevent vertebral and hip fracture. Strontium ranelate has side effect benefits over the bisphosphonates, as it does not cause any form of upper GI side effect, which is the most common cause for medication withdrawal in osteoporosis. In studies a small increase in the risk of venous thromboembolism was noted,[36] the cause for which has not been determined. This suggests it may be less suitable in patients at risk for thrombosis for different reasons. The uptake of (heavier) strontium in place of calcium into bone matrix results in a substantial and disproportionate increase in bone mineral density as measured on DXA scanning[37], making further followup of bone density by this method harder to interpret for strontium treated patients. A correction algorithm has been devised.[38]

    Although strontium ranelate is effective, it's not approved for use in the United States yet. However, strontium citrate is available in the U.S. from several well-known vitamin manufacturers. Most researchers believe that strontium is safe and effective no matter what form it's used. The ranelate form is simply a device invented by the Servier company of France so that they could patent their version of strontium.[citation needed]

    Strontium, no matter what the form, must be water-soluble and ionized in the stomach acid. Strontium is then protein-bound for transport from the intestinal tract into the blood stream. Unlike drugs like sodium alendronate (Fosamax), strontium doesn't inhibit bone recycling and, in fact, may produce stronger bones. Studies have shown that after five years alendronate may even cause bone loss, while strontium continues to build bone during lifetime use.[citation needed]

    Strontium must not be taken with food or calcium-containing preparations as calcium competes with strontium during uptake. However, it's essential that calcium, magnesium, and vitamin D in therapeutic amounts must be taken daily, but not at the same time as strontium. Strontium should be taken on an empty stomach at night.[citation needed]

    Hormone replacement

    Estrogen replacement therapy remains a good treatment for prevention of osteoporosis but, at this time, is not recommended unless there are other indications for its use as well. There is uncertainty and controversy about whether estrogen should be recommended in women in the first decade after the menopause.

    In hypogonadal men testosterone has been shown to give improvement in bone quantity and quality, but, as of 2008, there are no studies of the effects on fractures or in men with a normal testosterone level.[20]

    Selective estrogen receptor modulator (SERM)

    SERMs are a class of medications that act on the estrogen receptors throughout the body in a selective manner. Normally, bone mineral density (BMD) is tightly regulated by a balance between osteoblast and osteoclast activity in the trabecular bone. Estrogen has a major role in regulation of the bone formation-resorption equilibrium, as it stimulates osteoblast activity. Some SERMs such as raloxifene, act on the bone by slowing bone resorption by the osteoclasts.[39] SERMs have been proved as effective in clinical trials.[40][41]

    Nutrition

    Calcium

    Calcium is required to support bone growth, bone healing and maintain bone strength and is one aspect of treatment for osteoporosis. Recommendations for calcium intake vary depending country and age; for individuals at higher risk of osteoporosis (after fifty years of age) the amount recommended by US health agencies is 1,200 mg per day. Calcium supplements can be used to increase dietary intake, and absorption is optimized through taking in several small (500 mg or less) doses throughout the day.[42] The role of calcium in preventing and treating osteoporosis is unclear — some populations with extremely low calcium intake also have extremely low rates of bone fracture, and others with high rates of calcium intake through milk and milk products have higher rates of bone fracture. Other factors, such as protein, salt and vitamin D intake, exercise and exposure to sunlight, can all influence bone mineralization, making calcium intake one factor among many in the development of osteoporosis.[43] In the report of WHO (World Health Organization) in 2007, because calcium is consumed by an acid load with food, it influences osteoporosis.[44][45].

    A meta-analysis of randomized controlled trials involving calcium and calcium plus vitamin D supported the use of high levels of calcium (1,200 mg or more) and vitamin D (800 IU or more), though outcomes varied depending on which measure was used to assess bone health (rates of fracture versus rates of bone loss).[46] The meta-analysis, along with another study, also supported much better outcomes for patients with high compliance to the treatment protocol.[47] In contrast, despite earlier reports in improved high density lipoprotein (HDL, "good cholesterol") in calcium supplementation, a possible increase in the rate of myocardial infarction (heart attack) was found in a study in New Zealand in which 1471 women participated. If confirmed, this would indicate that calcium supplementation in women otherwise at low risk of fracture may cause more harm than good.[48]

    Vitamin D

    Some studies have shown that a high intake of vitamin D reduces fractures in the elderly,[46][49] though the Women's Health Initiative found that though calcium plus vitamin D did increase bone density, it did not affect hip fracture but did increase formation of kidney stones.[50]

    Exercise

    Multiple studies have shown that aerobics, weight bearing, and resistance exercises can all maintain or increase BMD in postmenopausal women.[51] Many researchers have attempted to pinpoint which types of exercise are most effective at improving BMD and other metrics of bone quality, however results have varied. One year of regular jumping exercises appears to increase the BMD and moment of inertia of the proximal tibia[52] in normal postmenopausal women. Treadmill walking, gymnastic training, stepping, jumping, endurance, and strength exercises all resulted in significant increases of L2-L4 BMD in osteopenic postmenopausal women.[53][54][55] Strength training elicited improvements specifically in distal radius and hip BMD.[56] Exercise combined with other pharmacological treatments such as hormone replacement therapy (HRT) has been shown to increases BMD more than HRT alone.[57]

    Additional benefits for osteoporotic patients other than BMD increase include improvements in balance, gait, and a reduction in risk of falls.[58]

    Prognosis

    Hip fractures per 1000 patient-years[59]
    WHO category Age 50-64 Age > 64 Overall
    Normal 5.3 9.4 6.6
    Osteopenia 11.4 19.6 15.7
    Osteoporosis 22.4 46.6 40.6

    Although osteoporosis patients have an increased mortality rate due to the complications of fracture, most patients die with the disease rather than of it.

    Hip fractures can lead to decreased mobility and an additional risk of numerous complications (such as deep venous thrombosis and/or pulmonary embolism, pneumonia). The 6-month mortality rate following hip fracture is approximately 13.5%, and a substantial proportion (almost 13%) of people who have suffered a hip fracture need total assistance to mobilize after a hip fracture.[60]

    Vertebral fractures, while having a smaller impact on mortality, can lead to severe chronic pain of neurogenic origin, which can be hard to control, as well as deformity. Though rare, multiple vertebral fractures can lead to such severe hunch back (kyphosis) that the resulting pressure on internal organs can impair one's ability to breathe.

    Apart from risk of death and other complications, osteoporotic fractures are associated with a reduced health-related quality of life.[61]

    Epidemiology

    Lateral thoraco-lumbar spine X-ray demonstrating multiple wedge fractures

    It is estimated[citation needed] that 1 in 3 women and 1 in 12 men over the age of 50 worldwide have osteoporosis. It is responsible for millions of fractures annually, mostly involving the lumbar vertebrae, hip, and wrist. Fragility fractures of ribs are also common in men.

    Hip fractures

    Hip fractures are responsible for the most serious consequences of osteoporosis. In the United States, more than 250,000 hip fractures annually are attributible to osteoporosis.[62] It is estimated that a 50-year-old white woman has a 17.5% lifetime risk of fracture of the proximal femur. The incidence of hip fractures increases each decade from the sixth through the ninth for both women and men for all populations. The highest incidence is found among those men and women ages 80 or older.[63]

    Vertebral fractures

    Between 35-50% of all women over 50 had at least one vertebral fracture. In the United States, 700,000 vertebral fractures occur annually, but only about a third are recognized. In a series of 9704 of women aged 68.8 on average studied for 15 years, 324 had already suffered a vertebral fracture at entry into the study; 18.2% developed a vertebral fracture, but that risk rose to 41.4% in women who had a previous vertebral fracture.[64]

    Wrist

    In the United States, 250,000 wrist fractures annually are attributable to osteoporosis.[62] Wrist fractures are the third most common type of osteoporotic fractures. The lifetime risk of sustaining a Colles' fracture is about 16% for white women. By the time women reach age 70, about 20% have had at least one wrist fracture.[63]

    Rib Fractures

    Fragility fractures of the ribs are common in men as young as age thirty-five on. These are often overlooked as signs of osteoporosis as these men are often physically active and suffer the fracture in the course of physical activity. An example would be as a result of falling while water skiing or jet skiing. However, a quick test of the individual's testosterone level following the diagnosis of the fracture will readily reveal whether that individual might be at risk.

    Prevention

    Methods to prevent osteoporosis include changes of lifestyle. However, there are medications that can be used for prevention as well. As a different concept there are osteoporosis ortheses which help to prevent spine fractures and support the building up of muscles. Fall prevention can help prevent osteoporosis complications.

    Lifestyle

    Lifestyle prevention of osteoporosis is in many aspects inversions from potentially modifiable risk factors. As tobacco smoking and unsafe alcohol intake have been linked with osteoporosis, smoking cessation and moderation of alcohol intake are commonly recommended in the prevention of osteoporosis.[citation needed]

    Exercise

    Achieving a higher peak bone mass through exercise and proper nutrition during adolescence is important for the prevention of osteoporosis. Exercise and nutrition throughout the rest of the life delays bone degeneration. Jogging, walking, or stair climbing at 70-90% of maximum effort three times per week, along with 1,500 mg of calcium per day, increased bone density of the lumbar (lower) spine by 5% over 9 months. Individuals already diagnosed with osteopenia or osteoporosis should discuss their exercise program with their physician to avoid fractures.[65]

    Nutrition

    Proper nutrition includes a diet sufficient in calcium and vitamin D. Patients at risk for osteoporosis (e.g. steroid use) are generally treated with vitamin D and calcium supplements and often with bisphosphonates. In renal disease, more active forms of Vitamin D such as paracalcitol or (1,25-dihydroxycholecalciferol or calcitriol which is the main biologically active form of vitamin D) is used, as the kidney cannot adequately generate calcitriol from calcidiol (25-hydroxycholecalciferol) which is the storage form of vitamin D.

    High dietary protein intake increases calcium excretion in urine and has been linked to increased risk of fractures in research studies.[66] Other investigations have shown that protein is required for calcium absorption, but that excessive protein consumption inhibits this process. No interventional trials have been performed on dietary protein in the prevention and treatment of osteoporosis.[67]

    Medication

    Just as for treatment, bisphosphonate can be used in cases of very high risk. Other medicines prescribed for prevention of osteoporosis include raloxifene, a selective estrogen receptor modulator (SERM).

    Estrogen replacement therapy remains a good treatment for prevention of osteoporosis but, at this time, is not recommended unless there are other indications for its use as well. There is uncertainty and controversy about whether estrogen should be recommended in women in the first decade after the menopause.

    In hypogonadal men testosterone has been shown to give improvement in bone quantity and quality, but, as of 2008, there are no studies of the effects on fractures or in men with a normal testosterone level.[20]

    History

    The link between age-related reductions in bone density and fracture risk goes back at least to Astley Cooper, and the term "osteoporosis" and recognition of its pathological appearance is generally attributed to the French pathologist Jean Lobstein.[68] The American endocrinologist Fuller Albright linked osteoporosis with the postmenopausal state.[69] Bisphosponates, which revolutionized the treatment of osteoporosis, were discovered in the 1960s.[70]

    Organisations

    The National Osteoporosis Society, established in 1986, is the only United Kingdom charity dedicated to improving the diagnosis, prevention and treatment of osteoporosis.[71][72]

    See also

    References

    1. ^ a b c WHO (1994). "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group". World Health Organization technical report series 843: 1–129. PMID 7941614. 
    2. ^ Frost HM, Thomas CC. Bone Remodeling Dynamics. Springfield, IL: 1963.
    3. ^ a b c d e f Raisz L (2005). "Pathogenesis of osteoporosis: concepts, conflicts, and prospects.". J Clin Invest 115 (12): 3318–25. doi:10.1172/JCI27071. PMID 16322775. http://www.jci.org/cgi/content/full/115/12/3318. 
    4. ^ Kim DH, Vaccaro AR (2006). "Osteoporotic compression fractures of the spine; current options and considerations for treatment". The spine journal : official journal of the North American Spine Society 6 (5): 479–87. doi:10.1016/j.spinee.2006.04.013. PMID 16934715. 
    5. ^ Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ (2007). "Will my patient fall?". JAMA 297 (1): 77–86. doi:10.1001/jama.297.1.77. PMID 17200478. 
    6. ^ Melton LJ (2003). "Epidemiology worldwide". Endocrinol. Metab. Clin. North Am. 32 (1): 1–13, v. doi:10.1016/S0889-8529(02)00061-0. PMID 12699289. 
    7. ^ Ojo F, Al Snih S, Ray LA, Raji MA, Markides KS (2007). "History of fractures as predictor of subsequent hip and nonhip fractures among older Mexican Americans". Journal of the National Medical Association 99 (4): 412–8. PMID 17444431. 
    8. ^ a b Poole KE, Compston JE (December 2006). "Osteoporosis and its management". BMJ 333 (7581): 1251–6. doi:10.1136/bmj.39050.597350.47. PMID 17170416. 
    9. ^ Berg KM, Kunins HV, Jackson JL et al. (2008). "Association between alcohol consumption and both osteoporotic fracture and bone density". Am J Med 121 (5): 406–18. doi:10.1016/j.amjmed.2007.12.012. 
    10. ^ a b Nieves JW (01 May 2005). "Osteoporosis: the role of micronutrients.". Am J Clin Nutr 81 (5): 1232S–1239S. PMID 15883457. http://www.ajcn.org/cgi/content/full/81/5/1232S. 
    11. ^ a b c d e f g h i j k l m n WHO Scientific Group on the Prevention and Management of Osteoporosis (2000 : Geneva, Switzerland) (2003). "Prevention and management of osteoporosis : report of a WHO scientific group" (pdf). http://whqlibdoc.who.int/trs/WHO_TRS_921.pdf. Retrieved on 2007-05-31. 
    12. ^ Wong PK, Christie JJ, Wark JD (2007). "The effects of smoking on bone health". Clin. Sci. 113 (5): 233–41. doi:10.1042/CS20060173. PMID 17663660. http://www.clinsci.org/cs/113/0233/cs1130233.htm. 
    13. ^ Shapses SA, Riedt CS (01 Jun 2006). "Bone, body weight, and weight reduction: what are the concerns?". J. Nutr. 136 (6): 1453–6. PMID 16702302. http://jn.nutrition.org/cgi/content/full/136/6/1453. 
    14. ^ Staessen J, Roels H, Emelianov D, Kuznetsova T, Thijs L, Vangronsveld J, Fagard R (Apr 3 1999). "Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group.". Lancet 353 (9159): 1140–4. doi:10.1016/S0140-6736(98)09356-8. PMID 10209978. 
    15. ^ Tucker KL, Morita K, Qiao N, Hannan MT, Cupples LA, Kiel DP (2006). "Colas, but not other carbonated beverages, are associated with low bone mineral density in older women: The Framingham Osteoporosis Study". Am. J. Clin. Nutr. 84 (4): 936–42. PMID 17023723. 
    16. ^ "Soft drinks in schools". Pediatrics 113 (1 Pt 1): 152–4. 2004. doi:10.1542/peds.113.1.152. PMID 14702469. 
    17. ^ Waugh EJ, Lam M-A, Hawker GA, et al. (2009). "Risk factors for low bone mass in healthy 40–60 year old women: A systematic review of the literature". Osteoporosis International 20 (1): 1–21. doi:10.1007/s00198-008-0643-x. 
    18. ^ a b c d e Simonelli, C et al. (July 2006). "ICSI Health Care Guideline: Diagnosis and Treatment of Osteoporosis, 5th edition" (PDF). Institute for Clinical Systems Improvement. http://www.icsi.org/osteoporosis/diagnosis_and_treatment_of_osteoporosis__3.html. Retrieved on 2008-04-08. 
    19. ^ a b c d e f g h i j k l Kohlmeier, Lynn Kohlmeier (1998). "Osteoporosis - Risk Factors, Screening, and Treatment". Medscape Portals. http://www.medscape.com/viewarticle/427342. Retrieved on 2008-05-11. 
    20. ^ a b c d Ebeling PR (2008). "Clinical practice. Osteoporosis in men". N Engl J Med 358 (14): 1474–82. doi:10.1056/NEJMcp0707217. PMID 18385499. 
    21. ^ Bone and Tooth Society of Great Britain, National Osteoporosis Society, Royal College of Physicians (2003). Glucocorticoid-induced Osteoporosis. London, UK: Royal College of Physicians of London. ISBN 1-860-16173-1. http://www.rcplondon.ac.uk/pubs/contents/966c62dd-8011-4f65-a61d-dd0c7fe4fa4b.pdf. 
    22. ^ Gourlay M, Franceschini N, Sheyn Y (2007). "Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures". Clin Rheumatol 26 (2): 144–53. doi:10.1007/s10067-006-0315-1. PMID 16670825. 
    23. ^ Petty SJ, O'Brien TJ, Wark JD (2007). "Anti-epileptic medication and bone health". Osteoporosis international 18 (2): 129–42. doi:10.1007/s00198-006-0185-z. PMID 17091219. 
    24. ^ Ruiz-Irastorza G, Khamashta MA, Hughes GR (2002). "Heparin and osteoporosis during pregnancy: 2002 update". Lupus 11 (10): 680–2. doi:10.1191/0961203302lu262oa. PMID 12413068. 
    25. ^ Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF (2006). "Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2". Arch. Intern. Med. 166 (2): 241–6. doi:10.1001/archinte.166.2.241. PMID 16432096. http://archinte.ama-assn.org/cgi/content/full/166/2/241. 
    26. ^ Yang YX, Lewis JD, Epstein S, Metz DC (2006). "Long-term proton pump inhibitor therapy and risk of hip fracture". JAMA 296: 2947–53. doi:10.1001/jama.296.24.2947. PMID 17190895. 
    27. ^ Murphy CE, Rodgers PT (2007). "Effects of thiazolidinediones on bone loss and fracture". Ann Pharmacother 41 (12): 2014–8. doi:10.1345/aph.1K286. PMID 17940125. 
    28. ^ Leib ES, Lewiecki EM, Binkley N, Hamdy RC (2004). "Official positions of the International Society for Clinical Densitometry". J Clin Densitom 7 (1): 1799. doi:10.1385/JCD:7:1:1. PMID 14742881.  quoted in: "Diagnosis of osteoporosis in men, premenopausal women, and children"
    29. ^ U.S. Preventive Services Task Force (2002). "Screening for osteoporosis in postmenopausal women: recommendations and rationale". Ann. Intern. Med. 137 (6): 526–8. PMID 12230355. 
    30. ^ Martínez-Aguilà D, Gómez-Vaquero C, Rozadilla A, Romera M, Narváez J, Nolla JM (2007). "Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit". J. Rheumatol. 34 (6): 1307–12. PMID 17552058. 
    31. ^ Schousboe JT, Taylor BC, Fink HA, et al. (2007). "Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men". JAMA 298 (6): 629–37. doi:10.1001/jama.298.6.629. PMID 17684185. 
    32. ^ Lyles KW, Colón-Emeric CS, Magaziner JS, et al. (2007). "Zoledronic acid and clinical fractures and mortality after hip fracture". N Engl J Med 357: published online 2007–09–17. doi:10.1056/NEJMoa074941. PMID 17878149. 
    33. ^ Purcell, P. Boyd, I (2005). "Bisphosphonates and osteonecrosis of the jaw". Medical Journal of Australia 182 (8): 417–418. 
    34. ^ "6.6.2 Bisphosphonates". British National Formulary (54 ed.). British Medical Association and Royal Pharmaceutical Society of Great Britain. September 2007. pp. p403. 
    35. ^ Meunier PJ, Roux C, Seeman E, et al. (2004). "The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis". N. Engl. J. Med. 350 (5): 459–68. doi:10.1056/NEJMoa022436. PMID 14749454. 
    36. ^ O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY (2006). "Strontium ranelate for preventing and treating postmenopausal osteoporosis". Cochrane database of systematic reviews (Online) (4): CD005326. doi:10.1002/14651858.CD005326.pub3. PMID 17054253. 
    37. ^ Reginster JY, Seeman E, De Vernejoul MC, et al. (2005). "Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study.". J Clin Endorinol Metab 90: 2816–22. doi:10.1210/jc.2004-1774. PMID 15728210. 
    38. ^ Blake GM, Fogelman I (2007). "The correction of BMD measurements for bone strontium content". J Clin Densitom 10 (3): 259–65. doi:10.1016/j.jocd.2007.03.102. PMID 17543560. 
    39. ^ Taranta A, Brama M, Teti A, et al. (February 2002). "The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro". Bone 30 (2): 368–76. doi:10.1016/S8756-3282(01)00685-8. PMID 11856644. http://linkinghub.elsevier.com/retrieve/pii/S8756328201006858. 
    40. ^ Meunier PJ, Vignot E, Garnero P, et al. (1999). "Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group". Osteoporos Int 10 (4): 330–6. doi:10.1007/s001980050236. PMID 10692984. http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm. 
    41. ^ Meunier PJ, Vignot E, Garnero P, et al. (1999). "Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group". Osteoporos Int 10 (4): 330–6. doi:10.1007/s001980050236. PMID 10692984. http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm. 
    42. ^ "Nutrition and Bone Health". NIAMS. 2005-11-01. http://www.niams.nih.gov/Health_Info/Bone/Bone_Health/Nutrition/default.asp. Retrieved on 2008-01-28. 
    43. ^ "Calcium & Milk". Harvard School of Public Health. 2007. http://www.hsph.harvard.edu/nutritionsource/calcium.html. Retrieved on 2008-01-28. 
    44. ^ Report of a Joint WHO/FAO/UNU Expert Consultation(2007) Protein and amino acid requirements in human nutrition, pp224-226. ISBN 978-92-4-120935-9
    45. ^ Report of a Joint WHO/FAO/UNU Expert Consultation(2002), Human Vitamin and Mineral Requirements, pp166-167.
    46. ^ a b Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007). "Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis". Lancet 370 (9588): 657–66. doi:10.1016/S0140-6736(07)61342-7. PMID 17720017. 
    47. ^ Prince RL, Devine A, Dhaliwal SS, Dick IM (2006). "Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women". Arch. Intern. Med. 166 (8): 869–75. doi:10.1001/archinte.166.8.869. PMID 16636212. 
    48. ^ Bolland MJ, Barber PA, Doughty RN, et al. (2008). "Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial". BMJ 336: 262. doi:10.1136/bmj.39440.525752.BE. PMID 18198394. 
    49. ^ Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B (2005). "Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials". JAMA 293 (18): 2257–64. doi:10.1001/jama.293.18.2257. PMID 15886381. 
    50. ^ Jackson RD, LaCroix AZ, Gass M, et al. (2006). "Calcium plus vitamin D supplementation and the risk of fractures". N. Engl. J. Med. 354 (7): 669–83. doi:10.1056/NEJMoa055218. PMID 16481635. 
    51. ^ Bonaiuti D, Shea B, Iovine R, et al. (2002). "Exercise for preventing and treating osteoporosis in postmenopausal women". Cochrane database of systematic reviews (Online) (3): CD000333. doi:10.1002/14651858.CD000333. PMID 12137611. 
    52. ^ Cheng S, Sipilä S, Taaffe DR, Puolakka J, Suominen H (2002). "Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women". Bone 31 (1): 126–35. doi:10.1016/S8756-3282(02)00794-9. PMID 12110425. 
    53. ^ Chien MY, Wu YT, Hsu AT, Yang RS, Lai JS (2000). "Efficacy of a 24-week aerobic exercise program for osteopenic postmenopausal women". Calcif. Tissue Int. 67 (6): 443–8. doi:10.1007/s002230001180. PMID 11289692. 
    54. ^ Iwamoto J, Takeda T, Ichimura S (2001). "Effect of exercise training and detraining on bone mineral density in postmenopausal women with osteoporosis". Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 6 (2): 128–32. doi:10.1007/s007760100059. PMID 11484097. 
    55. ^ Kemmler W, Engelke K, Weineck J, Hensen J, Kalender WA (2003). "The Erlangen Fitness Osteoporosis Prevention Study: a controlled exercise trial in early postmenopausal women with low bone density-first-year results". Archives of physical medicine and rehabilitation 84 (5): 673–82. PMID 12736880. 
    56. ^ Kerr D, Morton A, Dick I, Prince R (1996). "Exercise effects on bone mass in postmenopausal women are site-specific and load-dependent". J. Bone Miner. Res. 11 (2): 218–25. PMID 8822346. 
    57. ^ Villareal DT, Binder EF, Yarasheski KE, et al. (2003). "Effects of exercise training added to ongoing hormone replacement therapy on bone mineral density in frail elderly women". J Am Geriatr Soc 51 (7): 985–90. doi:10.1046/j.1365-2389.2003.51312.x. PMID 12834519. 
    58. ^ Sinaki M, Brey RH, Hughes CA, Larson DR, Kaufman KR (2005). "Significant reduction in risk of falls and back pain in osteoporotic-kyphotic women through a Spinal Proprioceptive Extension Exercise Dynamic (SPEED) program". Mayo Clin Proc 80 (7): 849–55. doi:10.4065/80.7.849. PMID 16007888. 
    59. ^ Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD (2007). "Low bone mineral density and fracture burden in postmenopausal women". CMAJ 177 (6): 575–80. doi:10.1503/cmaj.070234. PMID 17846439. 
    60. ^ Hannan EL, Magaziner J, Wang JJ, et al. (2001). "Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes". JAMA 285 (21): 2736–42. doi:10.1001/jama.285.21.2736. PMID 11386929. 
    61. ^ Brenneman SK, Barrett-Connor E, Sajjan S, Markson LE, Siris ES (2006). "Impact of recent fracture on health-related quality of life in postmenopausal women". J. Bone Miner. Res. 21 (6): 809–16. doi:10.1359/jbmr.060301. PMID 16753011. 
    62. ^ a b Riggs, B.L.; Melton, Lj 3.r.d. (2005). "The worldwide problem of osteoporosis: insights afforded by epidemiology.". Bone. PMID 8573428. 
    63. ^ a b "MerckMedicus Modules: Osteoporosis - Epidemiology". Merck & Co., Inc. http://www.merckmedicus.com/pp/us/hcp/diseasemodules/osteoporosis/epidemiology.jsp. Retrieved on 2008-06-13. 
    64. ^ Cauley JA, Hochberg MC, Lui LY et al. (2007). "Long-term Risk of Incident Vertebral Fractures". JAMA 298: 2761–2767. doi:10.1001/jama.298.23.2761. PMID 18165669. 
    65. ^ Dalsky GP, Stocke KS, Ehsani AA, Slatopolsky E, Lee WC, Birge SJ (1988). "Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women". Ann. Intern. Med. 108 (6): 824–8. PMID 3259410. 
    66. ^ Feskanich D, Willett WC, Stampfer MJ, Colditz GA (1996). "Protein consumption and bone fractures in women". Am. J. Epidemiol. 143 (5): 472–9. PMID 8610662. 
    67. ^ Kerstetter JE, O'Brien KO, Insogna KL (2003). "Dietary protein, calcium metabolism, and skeletal homeostasis revisited". Am. J. Clin. Nutr. 78 (3 Suppl): 584S–592S. PMID 12936953. 
    68. ^ Lobstein JGCFM. Lehrbuch der pathologischen Anatomie. Stuttgart: Bd II, 1835.
    69. ^ Albright F, Bloomberg E, Smith PH (1940). "Postmenopausal osteoporosis". Trans. Assoc. Am. Physicians. 55: 298–305. 
    70. ^ Patlak M (2001). "Bone builders: the discoveries behind preventing and treating osteoporosis". Faseb J. 15 (10): 1677E–E. doi:10.1096/fj.15.10.1677e. PMID 11481214. 
    71. ^ "About Us", National Osteoporosis Society.
    72. ^ "£3million Award Towards The Improvement Of Osteoporosis Services, UK", Medical News Today, 17 March 2008.

    External links



     
    Translations: Osteoporosis
    Top

    Dansk (Danish)
    n. - osteoporosis, knogleskørhed

    Nederlands (Dutch)
    osteoporose, ontkalking van botten, breuk veroorzaakt door ontkalking

    Français (French)
    n. - ostéoporose

    Deutsch (German)
    n. - Osteoporose

    Ελληνική (Greek)
    n. - (παθολ.) οστεοπόρωση

    Italiano (Italian)
    osteoporosi

    Português (Portuguese)
    n. - osteoporose (f)

    Русский (Russian)
    остеопороз

    Español (Spanish)
    n. - osteoporosis

    Svenska (Swedish)
    n. - osteoporis (benskörhet)

    中文(简体)(Chinese (Simplified))
    骨质疏松症

    中文(繁體)(Chinese (Traditional))
    n. - 骨質疏鬆症

    한국어 (Korean)
    n. - 골다공증

    日本語 (Japanese)
    n. - 骨多孔症, 骨粗鬆症

    العربيه (Arabic)
    ‏(الاسم) مرض هشاشه العظام‏

    עברית (Hebrew)
    n. - ‮בריחת סידן, אוסטיאופורוזיס‬


     
     

    Did you mean: osteoporosis (disease), How serious is osteoporosis? (anatomy)


     

    Copyrights:

    Medical Encyclopedia. © 2006 through a partnership of Answers Corporation. All rights reserved.  Read more
    Dictionary. The American Heritage® Dictionary of the English Language, Fourth Edition Copyright © 2007, 2000 by Houghton Mifflin Company. Updated in 2007. Published by Houghton Mifflin Company. All rights reserved.  Read more
    Sci-Tech Encyclopedia. McGraw-Hill Encyclopedia of Science and Technology. Copyright © 2005 by The McGraw-Hill Companies, Inc. All rights reserved.  Read more
    World of the Body. The Oxford Companion to the Body. Copyright © 2001, 2003 by Oxford University Press. All rights reserved.  Read more
    Food and Nutrition. A Dictionary of Food and Nutrition. Copyright © 1995, 2003, 2005 by A. E. Bender and D. A. Bender. All rights reserved.  Read more
    Food and Fitness. Food and Fitness: A Dictionary of Diet and Exercise. Copyright © 1997, 2003 by Oxford University Press. All rights reserved.  Read more
    Dental Dictionary. Mosby's Dental Dictionary. Copyright © 2004 by Elsevier, Inc. All rights reserved.  Read more
    Alternative Medicine Encyclopedia. Encyclopedia of Alternative Medicine. Copyright © 2005 by The Gale Group, Inc. All rights reserved.  Read more
    Encyclopedia of Public Health. Encyclopedia of Public Health. Copyright © 2002 by The Gale Group, Inc. All rights reserved.  Read more
    Britannica Concise Encyclopedia. Britannica Concise Encyclopedia. © 2006 Encyclopædia Britannica, Inc. All rights reserved.  Read more
    Sports Science and Medicine. The Oxford Dictionary of Sports Science & Medicine. Copyright © Michael Kent 1998, 2006, 2007. All rights reserved.  Read more
    Columbia Encyclopedia. The Columbia Electronic Encyclopedia, Sixth Edition Copyright © 2003, Columbia University Press. Licensed from Columbia University Press. All rights reserved. www.cc.columbia.edu/cu/cup/  Read more
    Health Dictionary. The New Dictionary of Cultural Literacy, Third Edition Edited by E.D. Hirsch, Jr., Joseph F. Kett, and James Trefil. Copyright © 2002 by Houghton Mifflin Company. Published by Houghton Mifflin. All rights reserved.  Read more
    Veterinary Dictionary. Saunders Comprehensive Veterinary Dictionary 3rd Edition. Copyright © 2007 by D.C. Blood, V.P. Studdert and C.C. Gay, Elsevier. All rights reserved.  Read more
    Wikipedia. This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Osteoporosis" Read more
    Translations. Copyright © 2007, WizCom Technologies Ltd. All rights reserved.  Read more